Next Article in Journal
A Novel Class of Tyrosyl-DNA Phosphodiesterase 1 Inhibitors That Contains the Octahydro-2H-chromen-4-ol Scaffold
Previous Article in Journal
Anticancer and Differentiation Properties of the Nitric Oxide Derivative of Lopinavir in Human Glioblastoma Cells
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

New 18(4→3)-Abeo-Abietanoids from Tripterygium wilfordii

1
State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China
2
College of Plant Protection, Fujian Agriculture and Forestry University, Fuzhou 350002, China
*
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
Molecules 2018, 23(10), 2467; https://doi.org/10.3390/molecules23102467
Submission received: 13 September 2018 / Revised: 21 September 2018 / Accepted: 25 September 2018 / Published: 26 September 2018
(This article belongs to the Section Natural Products Chemistry)

Abstract

:
Three 18(4→3)-abeo-abietanoids, a new natural product and two new compounds, named tripordolides A–C (13), were isolated from the leaves of Tripterygium wilfordii. Their structures were elucidated on the basis of their spectroscopic analysis, and the absolute configuration of compounds was confirmed by CD and X-ray crystallographic analysis using anomalous scattering of Cu Kα radiation. Compounds 1 and 3 showed moderate inhibitory activities against NO production in lipopolysaccharide-induced (LPS) RAW 264.7 macrophages in vitro.

Graphical Abstract

1. Introduction

Tripterygium wilfordii, also called “leigongteng”, is a member of the Celastracrae family [1], and was commonly used in Traditional Chinese Medicines to cure IgA nephropathy cancer, systemic lupus erythematosus, ankylosing spondylitis, psoriasis, and idiopathic diseases [2,3,4]. Earlier chemical studies on T. wilfordii have led to the isolation of alkaloids [5,6,7], diterpenes [8], triterpenes [9], sesquiterpenes [10,11,12], and lignans [13], which showed a wide range of biological activity, including anti-fertility, anti-inflammatory, immunosuppressive, anti-HIV, and anti-tumor [14]. In order to explore structurally and biologically interesting natural products from T. wilfordii, three new 18(4→3)-abeo-abietanoids (Figure 1), containing a new natural product and two new compounds, named tripordolides A–C (13), were isolated. Herein, we describe the isolation, structural elucidation, and activities of these compounds.

2. Results and Discussion

Tripordolide A (1) was obtained as a colorless needle, and gave a positive reaction in the kedde reagent test on the TLC, which suggested the structure of compound 1 contained the lactone ring. Its molecular formula of C20H26O7 was determined on the basis of HRESIMS at m/z 379.17532 [M + H]+ (calculated for C20H27O7: 379.17513), indicating eight degrees of unsaturation. The 1H NMR spectrum data of 1 (Table 1) exhibited signals of three methyl groups [δH 1.12 (6H, s, H3-16 and H3-17)], two aromatic methines [δH 6.10 (1H, d, overlap) and 6.12 (1H, d, overlap)], an oxygenated methylene [δH 4.77(2H, m)], and two oxygenated methines [δH 3.96(1H, d, J = 2.8 Hz, H-7; 3.99 (1H, d, J = 6.0 Hz)]. The 13C NMR and DEPT spectra demonstrated 20 carbons resonances, which contained a carbonyl, seven oxygenated carbons (four quaternary carbons, a methylene, and two methines), two aromatic quaternary carbons, and two aromatic methenes. According to this information, the skeleton of 1 was recognized to be an 18(4→3)-abeo-abietane [15], which contained five rings and four hydroxy groups to be satisfied with its indices of hydrogen deficiency. Its planar structure and 1H, 13C NMR assignments could be confirmed with an analysis of the two-dimensional NMR (Figure 2). A ring of α, β-unsaturated-γ-lactone was confirmed based on the HMBC correlation from H2-19 [δH 4.77 (2H, m)] to C-18(δC 173.5) and C-3(δC 122.8). Structure of rings A and B could be determined by the 1H, 1H COSY correlations of H-1/H-2 and H-5/H-6/H-7, and the HMBC correlation of H3-20 [δH 1.00 (3H, s)]/C-1 (δC 27.5), C-5 (δC 35.1), C-9 (δC 76.0), and C-10 (δC 40.2). The HMBC Correlations from H-12 to C-9, C-13 (δC 82.7), C-14 (δC 77.6), and C-15 (δC 70.5); from H-14 [δH 3.99 (1H, d, J = 6.0 Hz)] to C-8 (δC 75.9) and C-13 corroborated the ring C. The four hydroxy groups were assigned to C-8, C-9, C-14, and C-15, indicated by the HMBC correlations of 8-OH [δH 4.86 (1H, s)]/C-7 (δC 74.3) and C-8, 9-OH [δH 4.03 (1H, s)]/C-10, C-11 (δC 134.0), and C-12 (δC 131.1), 15-OH [δH 4.15 (1H, s)]/C-13, C-15, C-16 (δC 24.3), and C-17 (δC 27.4); the 1H, 1H COSY correlation from H-14 to 14-OH [δH 4.90 (1H, d, J = 6.0 Hz)]. Finally, the fifth ring was an oxide bridge between C-7 and C-13 (furan ring) to meet with the HRESIMS data.
NOESY analysis was used to deduce the relative configuration of 1 (Figure 3). Orientations were confirmed by the NOE correlations of H3-20/8-OH, 9-OH and H-6β; of H-6β /H-7/H-14. Finally, the proposed structure of 1 was confirmed by an X-ray crystallography analysis using anomalous scattering of Cu Kα radiation (Figure 4). Accordingly, the absolute configuration of 5S, 7R, 8S, 9R, 10S, 13S, and 14S was established based on the value of the Flack absolute structure parameter—0.02(11).
Tripordolide B (2) was obtained as a colorless oil and showed a [M + Na]+ ion peak at m/z 399.1052 (calculated for 399.1050) in the HRESIMS, which corresponded to the molecular formula C19H20O8. Some obvious signals, a ring of α, β-unsaturated-γ-lactone [δH 5.42 (2H, m, H-17); δC 170.4 (C-18), 68.9 (C-19), 124.4 (C-3), and 146.5 (C-4)] and an oxygen isopropyl group [δH 1.23, 1.41 (each 3H, s, H3-16 and H3-17); δC 25.2(C-16), 26.8 (C-17), and 73.6 (C-15)], indicated 2 was also an 18(4→3)-abeo-abietane derivative (Table 1) and similar to a less 20-CH3 and aromatized nor-abietane, tripterlide F [16]., This was proven by the HMBC correlations of H-1 [δH 7.22 (1H, d, J = 8.0 Hz)]/C-4, C-5 (δC 128.7) and C-9 (δC 60.7); of H-2 [δH 7.70 (1H, d, J = 8.0 Hz)]/C-4, C-10 (δC 138.5) and C-18 (Figure 2). Some major differences between the two compounds in the chemical shift values of C-12 and C-13 were observed, which could be attributed to the breakage of a trisubstituted epoxide between C-12 (δC 69.7) and C-13 (δC 74.9). Furthermore, compared to the tripterlide F, the oxygen isopropyl group of 2 also lead to the lower field of C-15 (δC 73.6), C-16 (δC 25.2), and C-17 (δC 26.8). The relative configuration was established by the NOESY correlations of H-12/H-1 and of H-7/H-14/H-12 (Figure 5). Thus, 2 was elucidated as shown, named tripordolide B.
Tripordolide C (3) was obtained as a colorless oil and had the molecular formula C20H26O7, deduced from the [M + Na]+ ion peak at m/z 401.1574 (calculated 401.1571). Its 1H and 13C NMR characteristics (Table 1) could be concluded; 3 was also an 18(4→3)-abeo-abietane derivative. Its planar structure has been confirmed by an analysis of a two-dimensional NMR (Figure 2). HMBC correlation of 15-OH [δH 4.17 (1H, s)]/C-15 (δC 69.6), C-16 (δC 27.4), and C-17 (δC 26.1); 1H, 1H COSY correlations of 7-OH [δH 5.34 (1H, d, J = 5.4 Hz)]/H-7 [δH 4.22 (1H, m)], 11-OH [δH 5.02 (1H, d, J = 8.0 Hz)]/H-11[δH 4.45 (1H, br d, J = 8.0 Hz)], and 14-OH [δH 4.86 (1H, d, J = 4.4 Hz)]/H-14 [δH 4.47 (1H, d, J = 4.4 Hz)] suggested that the four hydroxy groups were located at C-7, C-11, C-14, and C-15. HMBC correlations from H3-20 [δH 1.05 (1H, s)] to C-5 (δC 40.8), C-10 (δC 35.6), and C-11 (δC 62.0), and from H-14 [δH 4.47 (1H, d, J = 4.4 Hz)] to C-8 (δC 131.7), C-9 (δC 137.8), C-12 (δC 55.9), and C-13 (δC 61.9) indicated a double bond between C-8 and C-9. Moreover, a trisubstituted epoxide between C-12 and C-13 was formed to meet with its indices of hydrogen deficiency, which also led the chemical shift of C-12 (δC 55.9) and C-13 (δC 61.9) to upfield. The relative configuration was established by the NOESY correlations of H-12/H-11/H-20 and of H-6β/H-7/H-14-OH (Figure 5). Therefore, 3 was elucidated as shown, named tripordolide C.
Three 18(4→3)-abeo-abietanes were evaluated for their inhibitory activities against NO production in lipopolysaccharide-induced (LPS) RAW 264.7 macrophages in vitro. Compounds 1 and 3 inhibited NO production in mouse peritoneal macrophage 48.4 ± 5.7% and 53.5 ± 4.8% at a concentration of 10 μM, while the positive control dexamethasone gave an inhibitory ratio of 63.1 ± 4.6% at an identical concentration.

3. Experimental Section

3.1. General

A Bruker APEX DUO diffractometer with Cu Kα radiation ((Bruker-Biospin, Billerica, MA, USA) was used to collect the X-ray data of compound 1. A JASCO P-2000 polarimeter (JASCO, Easton, MD, USA), JASCO V650 (Thermo Scientific, Waltham, MA, USA), spectrophotometer, and XT-5B micro melting point apparatus (Aihuishi Ltd. Shanghai, China) were used to collect optical rotations, UV spectra, and melting points, respectively. VNS-600 and Bruker-500 (Bruker-Biospin, Billerica, MA, USA) spectrometers were used to collected NMR spectra. The Agilent 1100 series LC/MSD ion trap mass spectrometer (Agilent, Waldbronn, Germany) was used to collect HRESIMS spectra. Preparative HPLC was performed on a Shimadzu LC-6AD instrument with a SPD-20A detector (Shimadzu Corp., Tokyo, Japan), using a YMC-Pack ODS-A column (2 × 25 cm, 5 μm, YMC, Tokyo, Japan). Column chromatography was performed with silica gel (200−300 mesh, Qingdao Marine Chemical Inc., Qingdao, China), polyamide (60–100 mesh, Changfeng Chemical Inc., Jiangsu, China), and ODS (50 μm, YMC, Tokyo, Japan).

3.2. Plant Material

The leaves of T. wilfordii were collected in Taining, Fujian, China, in September 2009 and identified by Professor Lin Ma from the Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College. A voucher specimen (No. 20090034) is deposited at the herbarium of the Institute of Materia Medica, Chinese Academy of Medical Sciences, and Peking Union Medical College, China.

3.3. Extraction and Isolation

The air-dried and powdered leaves of Tripterygium wilfordii (100 kg) were extracted two times with 80% EtOH (800 L) at 80 °C for 2 h. After filtration and evaporation ethanol under reduced pressure at 50 °C, the aqueous residue was diluted with H2O and then partitioned three times with ethyl acetate (30 L). The remaining water extract was subjected to passage over polyamide by elution with water and 30%, 60%, and 95% EtOH-H2O. Then the water elution was subjected to passage over D101 macroporous resin by elution successively with H2O, 30%, 60%, and 95% EtOH-H2O (Fractions B1-B4). Fraction B3 (338.5 g) was subjected to passage over a bergmeal column eluting successively with ethyl acetate, ethanol, and methanol (Fractions C1–C3). Fraction C2 (151.3 g) was chromatographed on a silica gel column eluting successively with a solvent gradient system (CHCl3−MeOH, 15:1−0:1) to afford 7 fractions (D1−D7). Fraction D4 (3.36 g) was passed over an PRP-512A macroporous resin column with MeOH-H2O (10%, 30%, 60% and 100%) to give four fractions (E1–E4), and the fraction E3 (0.45 g) was purified by preparative HPLC (MeOH-H2O, 35:65, v/v, detected at 210 nm, 8 mL/min) to give 1 (5.3mg), 2 (1.3 mg), and 3 (1.0 mg).

3.4. Spectral Data

Single crystals of C20H26O7 were recrystallized from MeOH mounted in inert oil and transferred to the cold gas stream of the diffractometer.
Crystal data of tripordolide A (1): C20H26O7, M = 378.41, monoclinic, a = 7.7259(3) Å, b = 7.3200(3) Å, c = 15.4365(5) Å, β = 98.081(3)°, U = 864.33(5) Å3, T = 105(2), space group P21 (no. 4), Z = 2, μ(Cu Kα) = 0.912, 6799 reflections measured, 3061 unique (Rint = 0.0282) which were used in all calculations. The final wR(F2) was 0.0901 (all data). Flack parameter was −0.02(11).
Crystallographic data for the structure of tripordolide A (1) have been deposited in the Cambridge Crystallographic Data Centre (deposition numbers: CCDC 1844652). Copies of the data can be obtained free of charge via www.ccdc.cam.ac.uk.

Characterization Data of Tripordolides A–C (13)

Tripordolide A (1): colorless needle; [α] D 25 —32.5 (c 0.1 MeOH); UV (MeOH) λmax (log ε) 220 (3.53) nm; 1H NMR (DMSO-d6, 500 MHz) and 13C NMR (DMSO-d6, 125 MHz), see Table 1; HRESIMS m/z 379.17532 [M + H]+ (calculated for C20H27O7, 379.17513). (Supplementary Materials).
Tripordolide B (2): colorless oil (MeOH); [α] D 25 —35.1 (c 0.1, MeOH); IR (microscope) νmax 3394, 2921, 1757, 1646, 1419, 1323, 1050, and 1027 cm−1; 1H NMR (DMSO-d6, 600 MHz) and 13C NMR (DMSO-d6, 150 MHz), see Table 1; HRESIMS m/z 399.1052 [M + Na]+ (calculated for C19H20NaO7, 399.1050). (Supplementary Materials).
Tripordolide C (3): colorless oil (MeOH); [α] D 25 —77.3 (c 0.1, MeOH); UV (MeOH) λmax (log ε) 220 (4.02) nm; 1H NMR (DMSO-d6, 600 MHz) and 13C NMR (DMSO-d6, 150 MHz), see Table 1; HRESIMS m/z 401.1574 [M + Na]+ (calculated for C20H26NaO7, 401.1571). (Supplementary Materials).

3.5. Biological Activities

The inhibitory effects of three compounds on NO production in LPS-induced RAW264.7 macrophage were evaluated. Dexamethasone was used a positive control. Concrete operation method was according to described in the literature [17].

4. Conclusions

In this research, no more than 30 18(4→3)-abeo-abietanes were isolated from the plant. Phytochemical studies on T. wilfordii have led to three abeo-abietanoids, a new natural product, and two new compounds, named tripordolides A–C (13). Tripordolide A (1) was reported in a patent as a synthetic product, but none of the spectra data was used as reference [18]. Its structure was elucidated on the basis of their spectroscopic analysis, and its absolute configuration was confirmed by an X-ray crystallographic analysis using anomalous scattering of Cu Kα radiation. Notably, tripordolide A (1) was the first example of 18(4→3)-abeo-abietanes, which possessed 7/13 oxygen bridges in the natural products. Compounds 1 and 3 showed moderate inhibitory activities against NO production in LPS-induced RAW 264.7 macrophage in vitro.

Supplementary Materials

The following are available online, copies of 1H, 13C NMR, DEPT, 1H, 1H COSY, HSQC, HMBC, NOESY and HRESIMS spectra of new compounds. This material is available free of charge online.

Author Contributions

Dongming Zhang designed the experiments and revised the paper; Lin Ni, Yingda Zang, Jing-zhi Yang, Chuang-jun Li, and Jie Ma performed the experiments, analyzed the data, and wrote the paper. All authors read and approved the final manuscript.

Funding

This work was supported by National Natural Science Foundation of China (No. 21572275), CAMS Innovation Fund for Medical Sciences (No. 2016-I2M-2-003), and the Educational and scientific research program for young and middle-age instructor of Fujian province (NO. JAT160173).

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Yu, L.; Ao, M.; Wan, J.; Zhang, Y. Anti-inflammatory effects of leaf and twig of Tripterygium wilfordii on paw edema in mice. Fitoterapia 2008, 79, 529–532. [Google Scholar] [CrossRef] [PubMed]
  2. Ji, W.; Li, J.; Lin, Y.; Song, Y.; Zhang, M.; Ke, Y.; Ren, Y.; Deng, X.; Zhang, J.; Huang, F.; et al. Report of 12 cases of ankylosing spondylitis patients treated with Tripterygium wilfordii. Clin. Rheumatol. 2010, 29, 1067–1072. [Google Scholar] [CrossRef] [PubMed]
  3. Ren, J.; Tao, Q.; Wang, X.; Wang, Z.; Li, J. Efficacy of T2 in active Crohn’s disease: A prospective study report. Dig. Dis. Sci. 2007, 52, 1790–1797. [Google Scholar] [CrossRef] [PubMed]
  4. Ji, S.; Wang, Q.; Chen, J.; Sha, G.; Liu, Z.; Li, L. Clinical trial of Tripterygium wilfordii Hook F. in human kidney transplantation in China. Transplant. Proc. 2006, 38, 1274–1279. [Google Scholar] [CrossRef] [PubMed]
  5. Wang, C.; Li, C.; Yang, J.; Ma, J.; Chen, X.; Hou, Q.; Zhang, D. Anti-inflammatory sesquiterpene derivatives from the leaves of Tripterygium wilfordii. J. Nat. Prod. 2013, 76, 85–90. [Google Scholar] [CrossRef] [PubMed]
  6. Chen, F.; Li, C.; Ma, J.; Zhou, J.; Li, L.; Zhao, Z.; Chen, N.; Zhang, D. Neuroprotective dihydroagarofuran sesquiterpene derivatives from the leaves of Tripterygium wilfordii. J. Nat. Prod. 2018, 81, 270–278. [Google Scholar] [CrossRef] [PubMed]
  7. Wang, C.; Li, C.; Ma, J.; Yang, J.; Chen, X.; Hou, Q.; Zhang, D. Bioactive sesquiterpene polyol esters from the leaves of Triptergium wilfordii. Fitoterapia 2014, 96, 103–108. [Google Scholar] [CrossRef] [PubMed]
  8. Duan, H.; Takaishi, Y.; Momota, H.; Ohmoto, Y.; Taki, T.; Jia, Y.; Li, D. Immunosuppressive diterpenoids from Tripterygium wilfordii. J. Nat. Prod. 1999, 62, 1522–1525. [Google Scholar] [CrossRef] [PubMed]
  9. Tanaka, N.; Duan, H.; Takaishi, Y.; Kawazoe, K.; Goto, S. Terpenoids from Tripterygium doianum (Celastraceae). Phytochemistry 2002, 61, 93–98. [Google Scholar] [CrossRef]
  10. Ni, L.; Zhang, X.; Zhou, X.; Ma, J.; Li, C.; Li, L.; Zhang, T.; Zhang, D. Megastigmane glycosides from the leaves of Tripterygium wilfordii. Nat. Prod. Comm. 2015, 10, 2023–2026. [Google Scholar]
  11. Ni, L.; Zhou, X.; Ma, J.; Zhang, X.; Li, C.; Li, L.; Yang, D.; Shao, Y.; Zhou, S.; Zhang, T.; et al. Wilfordonols A-D: Four new norsesquiterpenes from the leaves of Tripterygium wilfordii. J. Asian Nat. Prod. Res. 2015, 17, 615–624. [Google Scholar] [CrossRef] [PubMed]
  12. Ni, L.; Li, L.; Qiu, Y.; Chen, F.; Li, C.; Ma, J.; Zhang, D. Triptergosidols A–D, nerolidol-type sesquiterpene glucosides from the leaves of Tripterygium wilfordii. Fitoterapia 2018, 128, 187–191. [Google Scholar] [CrossRef] [PubMed]
  13. Cao, X.; Li, C.; Yang, J.; Wei, B.; Yuan, P.; Luo, Y.; Hou, Q.; Zhang, D. Four new neolignans from the leaves of Tripterygium wilfordii. Fitoterapia 2012, 83, 343–347. [Google Scholar] [CrossRef] [PubMed]
  14. Zhou, Z.; Yang, Y.; Ding, J.; Li, Y.; Miao, Z. Triptolide: Structural modifications, structure-activity relationship, bioactivities, clinical development and mechanisms. Nat. Prod. Rep. 2012, 29, 457–475. [Google Scholar] [CrossRef] [PubMed]
  15. Ni, L.; Ma, J.; Li, C.; Li, L.; Guo, J.; Yuan, S.; Hou, Q.; Guo, Y.; Zhang, D. Novel rearranged and highly oxygenated abietane diterpenoids from the leaves of Tripterygium wilfordii. Tetra. Lett. 2015, 56, 1239–1243. [Google Scholar] [CrossRef]
  16. Wang, C.; Li, C.; Ma, J.; Yang, J.; Chen, X.; Li, L.; Zhang, D. Bioactive 18(4→3)-abeo-abietanoid derivatives from the leaves of Tripterygium wilfordii. RSC Adv. 2015, 5, 30046–30052. [Google Scholar] [CrossRef]
  17. Wang, D.; Mu, Y.; Dong, H.; Yan, H.; Hao, C.; Wang, X.; Zhang, L. Chemical constituents of the ethyl acetate extract from Diaphragma juglandis fructus and their inhibitory activity on nitric oxide production in vitro. Molecules 2018, 23, 72. [Google Scholar] [CrossRef] [PubMed]
  18. Michel, J.; Mahinda, W.; Michael, H. Preparation of Triptolide Derivatives Useful in the Treatment of Autoimmune Diseases. U.S. Pantent US5972998, 26 October 1999. [Google Scholar]
Sample Availability: Samples of the compounds 13 are available from the authors.
Figure 1. The structures of compounds 13.
Figure 1. The structures of compounds 13.
Molecules 23 02467 g001
Figure 2. Key 1H,1H COSY and HMBC correlations of compounds 13.
Figure 2. Key 1H,1H COSY and HMBC correlations of compounds 13.
Molecules 23 02467 g002
Figure 3. Key NOESY correlations of compound 1.
Figure 3. Key NOESY correlations of compound 1.
Molecules 23 02467 g003
Figure 4. Single crystal structure of compound 1.
Figure 4. Single crystal structure of compound 1.
Molecules 23 02467 g004
Figure 5. Key NOESY correlations of compounds 2 and 3.
Figure 5. Key NOESY correlations of compounds 2 and 3.
Molecules 23 02467 g005
Table 1. 1H and 13C NMR data of compounds 13.
Table 1. 1H and 13C NMR data of compounds 13.
NO.123
δHa (mult., J/Hz)δCbδHc (mult., J/Hz)δCdδHc (mult., J/Hz)δCd
11.59, m; 1.89, m27.57.22, d (8.0)124.61.34, m; 2.18, m29.8
22.03, m; 2.15, m17.17.70, d (8.0)123.12.12, m; 2.25, m17.4
3 122.8 124.4 122.8
4 164.8 146.5 164.0
52.49, m35.1 128.72.54, m40.8
61.64, m; 1.53, m24.62.50, m; 2.50, m25.01.68, m; 2.06, m30.2
73.96, d (2.8)74.33.62, t (1.9)58.34.22, m70.6
8 75.9 60.4 131.7
9 76.0 60.7 137.8
10 40.2 138.5 35.6
116.12, d (overlap)134.03.68, d (5.0)66.74.45, br d (8.0)62.0
126.10, d (overlap)131.14.10, m69.73.34, d (overlap)55.9
13 82.7 74.9 61.9
143.99, d (6.0)77.63.58, dd (7.8, 5.2)74.84.47, d (4.4)67.5
15 70.5 73.6 69.6
161.12, s24.31.23, s25.21.27, s27.4
171.12, s27.41.41, s26.81.26, s26.1
18 173.5 170.4 173.5
194.77, m70.45.42, m68.94.82, m70.3
201.00, s13.1 1.05, s21.5
7-OH 5.34, d (5.4)
8-OH4.86, s
9-OH4.03, s
11-OH 5.02, d (8.0)
14-OH4.90, d(6.0 ) 4.86, d (4.4)
15-OH4.15, s 4.17, s
a In DMSO-d6 (500 MHz); b In DMSO-d6 (125 MHz). c In DMSO-d6 (600 MHz); d In DMSO-d6 (150 MHz).

Share and Cite

MDPI and ACS Style

Ni, L.; Zang, Y.-d.; Yang, J.-z.; Li, C.-j.; Ma, J.; Zhang, D.-m. New 18(4→3)-Abeo-Abietanoids from Tripterygium wilfordii. Molecules 2018, 23, 2467. https://doi.org/10.3390/molecules23102467

AMA Style

Ni L, Zang Y-d, Yang J-z, Li C-j, Ma J, Zhang D-m. New 18(4→3)-Abeo-Abietanoids from Tripterygium wilfordii. Molecules. 2018; 23(10):2467. https://doi.org/10.3390/molecules23102467

Chicago/Turabian Style

Ni, Lin, Ying-da Zang, Jing-zhi Yang, Chuang-jun Li, Jie Ma, and Dong-ming Zhang. 2018. "New 18(4→3)-Abeo-Abietanoids from Tripterygium wilfordii" Molecules 23, no. 10: 2467. https://doi.org/10.3390/molecules23102467

Article Metrics

Back to TopTop